{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:40:03Z","timestamp":1750534803662,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We report the intraoperative radioguided localization of an occult well-differentiated neuroendocrine tumor of the ileum in a patient with a known neuroendocrine lymphonodal metastasis in the mesentery. Preoperative imaging included CT, PET\/CT with <jats:sup>68<\/jats:sup>Ga-DOTATOC, and SPECT\/CT with <jats:sup>99m<\/jats:sup>Tc-HYNICTOC. These scans revealed morphological and functional properties of the primary tumor localized in the ileum. The day after IV <jats:sup>99m<\/jats:sup>Tc-HYNICTOC injection, the patient underwent surgery, and the target lesion was intraoperatively detected by a collimated handheld \u03b3-probe. Postoperative pathology examination confirmed the target lesion to be a neuroendocrine tumor of the ileum.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004971","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T22:00:17Z","timestamp":1701727217000},"page":"69-70","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Intraoperative Radioguided Localization of an Occult Neuroendocrine Tumor of the Ileum"],"prefix":"10.1097","volume":"49","author":[{"given":"Gianpiero","family":"Manca","sequence":"first","affiliation":[{"name":"Regional Center of Nuclear Medicine, University Hospital of Pisa, Pisa."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Nonne","sequence":"additional","affiliation":[{"name":"Regional Center of Nuclear Medicine, University Hospital of Pisa, Pisa."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duccio","family":"Volterrani","sequence":"additional","affiliation":[{"name":"Regional Center of Nuclear Medicine, University Hospital of Pisa, Pisa."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1007\/s11605-021-05115-w","article-title":"Radioguided surgery for gastroenteropancreatic neuroendocrine tumours: a systematic literature review","volume":"25","year":"2021","journal-title":"J Gastrointest Surg"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","year":"2020","journal-title":"Ann Oncol"},{"key":"bib3-20250621","first-page":"311","article-title":"Somatostatin receptor PET ligands\u2014the next generation for clinical practice","volume":"8","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00259-017-3728-y","article-title":"Guideline for PET\/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5603\/NMR.2017.0003","article-title":"Radioguided surgery with radiolabeled somatostatin analogs: not only in GEP-NETs","volume":"20","year":"2017","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.3748\/wjg.14.5377","article-title":"Neuroendocrine tumors of the gastro-entero-pancreatic system","volume":"14","year":"2008","journal-title":"World J Gastroenterol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00259-007-0476-4","article-title":"Radio-guided surgery with the use of [99mTc-EDDA\/HYNIC]octreotate in intra-operative detection of neuroendocrine tumours of the gastrointestinal tract","volume":"34","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s002590000289","article-title":"99mTc-EDDA\/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives","volume":"27","year":"2000","journal-title":"Eur J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:04:16Z","timestamp":1750532656000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004971","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}